{"@id":"https://bioecon.ru/technology/fecal-microbiota-transplantation/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/fecal-microbiota-transplantation/","json":"https://cn.bioecon.ru/api/v1/technology/fecal-microbiota-transplantation/index.json"},"id":"fecal-microbiota-transplantation","industries":["advanced-therapies","pharma","services"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/advanced-therapies/","https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/services/"],"suppliers":["https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/colgate-palmolive/","https://bioecon.ru/companies/food-first-llc/","https://bioecon.ru/companies/rubinum/","https://bioecon.ru/companies/vemo-corp/","https://bioecon.ru/companies/jindalai-environmental/","https://bioecon.ru/companies/goodbiopak/"]},"maturity":8,"name":"粪便微生物群移植（FMT标准化活体生物药与口服芽孢菌群胶囊）","regions":["us","cn","eu"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-15","entity":"fda.gov","kind":"official","urls":["https://www.fda.gov/vaccines-blood-biologics/rebyota","https://www.fda.gov/vaccines-blood-biologics/vowst"]},{"date":"2026-11-15","entity":"sciencedirect.com","kind":"research","urls":["https://doi.org/10.1016/j.cgh.2023.04.015"]}],"stages":[{"n":1,"title":null},{"n":2,"title":null},{"n":3,"title":null},{"n":4,"title":null},{"n":5,"title":null}],"summary":"基于严格供体筛查、厌氧纯化及纯化芽孢菌群的标准化活体生物药（LBP），通过重塑肠道次级胆汁酸代谢与定植抗力，根除复发性艰难梭菌感染及严重肠道菌群失调。","url":"/technology/fecal-microbiota-transplantation/","verified":"2026-11-15"}